Exicure (NASDAQ:XCUR) Issues Earnings Results

Exicure (NASDAQ:XCUR) posted its quarterly earnings data on Tuesday. The company reported ($3.39) EPS for the quarter, Zacks reports.

Exicure Stock Performance

NASDAQ:XCUR traded down $0.59 during mid-day trading on Tuesday, hitting $12.40. The stock had a trading volume of 36,996 shares, compared to its average volume of 567,374. The stock has a market cap of $32.31 million, a price-to-earnings ratio of -5.99 and a beta of 3.84. Exicure has a twelve month low of $1.44 and a twelve month high of $36.00. The company’s 50 day simple moving average is $10.28 and its 200 day simple moving average is $9.31.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.